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KAJIAN FITOKIMIA DAN AKTIVITI BIOLOGI BAGI GARCINIA 
HOMBRONIANA 
ABSTRAK 
Kajian ini ialah laporan pertama yang menggambarkan kajian fitokimia dan aktiviti 
biologi bagi kulit batang G. hombroniana. Ekstrak diklorometana dan etil asetat bagi 
kulit pokok Garcinia hombroniana yang dipisahkan secara kromatografi turus telah 
memberikan 4 sebatian baru (DN8, DN9, EN2 dan EN5) dan 14 sebatian yang telah 
diketahui (DN1-DN7, DN10, EN1, EN3, EN4, EN6-EN8). Struktur bagi semua 
sebatian baru telah dicirikan secara kaedah spektroskopi UV, IR dan 1D dan 2D 
NMR, EI-MS dan ESI-MS. Kesemua sebatian yang diketahui telah dikenalpasti dan 
ditentukan secara perbandingan data spektroskopi sebatian ini dengan data yang telah 
dilaporkan. 
Ekstrak mentah telah dikaji bagi menentukan jumlah kandungan fenolik dan 
jumlah kandungan flavonoid. Antioksidan, antibakteria dan aktiviti perencat 
kolinesterase bagi ekstrak tersebut dan beberapa sebatian tulen turut dikaji. Sebatian 
DN6 dan EN2 juga telah dikaji bagi aktiviti sitotoksik. Ekstrak etil asetat dan 
metanol telah menunjukkan kandungan fenolik yang sama manakala kandungan 
flavonoid didapati lebih tinggi dalam ekstrak etil asetat. Kesemua ekstrak polar telah 
menunjukkan aktiviti antioksidan yang ketara dalam ujian DPPH, ABTS dan FRAP. 
Bagi sebatian tulen yang dikaji EN2, EN3, EN4, EN8 dan DN9 telah menunjukkan 
aktiviti memerangkap radikal yang paling tinggi dalam cerakin DPPH. Aktiviti 
tersebut adalah lebih tinggi berbanding aktiviti memerangkap radical bagi rujukan 
piawai, Trolox. Sebatian EN2, EN8 dan EN3 juga menunjukkan aktiviti 
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pemerangkapan yang paling tinggi dalam ujian ABTS, iaitu tiga kali lebih tinggi 
berbanding aktiviti Trolox tetapi hampir sama dengan aktiviti pememerangkapan 
sebatian rujukan, asid gallik. 
Dalam asai aktiviti antibakteria terhadap dua bakteria Gram positif, 
Staphylococcus aureus, Bacillus subtilis dan dua bakteria Gram negatif, 
Pseudomonas aeruginosa dan Escherichia coli, ekstrak diklorometana telah 
merencatkan pertumbuhan B. subtilis dan P. aeruginosa, dengan nilai MIC 62.5 
µg/mL. Akan tetapi, ekstrak metanol dan air didapati tidak aktif terhadap kesemua 
strain bakteria yang dikaji. Aktiviti antibakteria bagi sebatian tulen DN1-DN10, EN1 
dan EN2 juga telah dikaji terhadap strain bakteria yang disebutkan di atas tetapi tiada 
yang menunjukkan aktiviti antibakteria. 
Dalam asai aktiviti perencatan kolinesterase, ekstrak etil asetat telah 
menunjukkan perencatan yang paling tinggi terhadap AChE dan BChE tetapi ekstrak 
metanol dan air telah menunjukkan perencatan yang sangat lemah. Antara sebatian 
tulen yang diuji (DN1-DN10 dan EN1-EN7), tulen DN4-DN7, DN9, DN10 dan EN2 
yang menunjukkan aktiviti perencatan terhadap AChE dan BChE.  
Sebatian tulen DN6 dan EN2 telah menunjukkan aktiviti sitotoksik yang 
lebih tinggi terhadap sel DBTRG berbanding sel PC-3, U2OS dan MCF-7. Aktiviti 
sitotoksik bagi sebatian tulen ini didapati bergantung kepada faktor leluhur sel, masa 
dan kepekatan.  
Keputusan kajian ini telah menonjolkan potensi kegunaan G. hombroniana 
dalam bidang perubatan tradisional dan penemuan ubat-ubatan.    
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PHYTOCHEMICAL AND BIOLOGICAL ACTIVITY STUDIES OF 
GARCINIA HOMBRONIANA 
ABSTRACT 
This study is the first report describing the phytochemical investigation and 
biological activities of the bark of G. hombroniana. The dichloromethane and ethyl 
acetate extracts of the bark of Garcinia hombroniana were separated by column 
chromatography to yield 4 new (DN8, DN9, EN2 and EN5) and 14 known (DN1-
DN7, DN10, EN1, EN3, EN4, EN6-EN8) compounds. The structures of the new 
compounds were characterized by spectroscopic techniques such as UV, IR, and 1D 
and 2D NMR, together with EI and ESI-MS spectrometric methods. The known 
compounds were identified and confirmed by comparison of their spectroscopic data 
with the reported literature.  
Crude extracts were examined for total phenolic and total flavonoids 
contents. Antioxidant, antibacterial and cholinesterase inhibitory activities of these 
extracts together with some selected pure compounds were also examined. 
Compounds DN6 and EN2 were further tested for cytotoxic activities. The ethyl 
acetate and methanol extracts showed equal phenolic contents, while flavonoids 
content was found to be higher in the ethyl acetate extract. All the polar extracts 
showed significant antioxidant activities by DPPH, ABTS and FRAP assays. For 
pure compounds EN2, EN3, EN4, EN8 and DN9, they showed the strongest 
scavenging activities in DPPH assay, all of which were higher than that of the 
referenced standard, Trolox. Compounds EN2, EN3 and EN8 also showed the 
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strongest scavenging activities in ABTS assay which is three times higher than that 
of Trolox and almost equal to that of the referenced compound, gallic acid.  
In the antibacterial activity assays which were carried out against two Gram 
positive bacteria, Staphylococcus aureus, Bacillus subtilis, and two Gram negative 
bacteria, Pseudomonas aeruginosa and Escherichia coli, the dichloromethane extract 
inhibited the growth of B. subtilis and P. aeruginosa, with a MIC value of 62.5 
µg/mL. However, the methanol and water extracts were found to be inactive towards 
all the tested bacterial strains. The pure compounds DN1-DN10, EN1 and EN2 were 
also tested for antibacterial activities against the aforementioned bacteria strain but 
none of them showed antibacterial activity. 
In cholinesterase inhibitory activity assays, ethyl acetate extract showed the 
strongest inhibition against AChE and BChE but methanol and water extracts 
showed very weak inhibition. Among the tested pure compounds (DN1-DN10 and 
EN1-EN7), compounds DN4-DN7, DN9, DN10 and EN2 showed inhibition against 
AChE and BChE.  
Pure compounds DN6 and EN2 possessed significant cytotoxic activities 
against DBTRG cells as compared with PC-3, U2OS and MCF-7 cells. The cytotoxic 
activities of these compounds were found to be cell-line, time and concentration 
dependent.  
Results of this study concluded the potential uses of G. hombroniana in 
traditional medicine and drug discovery. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Natural Products 
The name “natural products” is given to compounds derived from natural 
sources such as plants, animals and microorganisms, which are used for self-defense 
and to enhance survival period (Williams et al., 1989).  More than 80,000 of 250,000 
species of plants are used as traditional medicine for healing purposes (Newman, 
2007). They can be either in crude forms or as pure compounds, derived from a 
whole plant or certain parts of a plant, or from exudates of plants (Joy et al., 2001).  
Today, about three-quarter of the world’s population used herbal medicine in their 
health care needs (Moerman, 1996). However, only a small percentage of plants have 
been evaluated for their phytochemical and pharmacological potential (Tringali et al., 
2001) while a large portion of which remains unknown. Interests in the use of 
traditional medicine are increasing rapidly due to their easy accessibility, a relatively 
low cost and low side effects to be used against various diseases including cancer, 
HIV/AIDS, and etcetera (Liang & Fang, 2006; WHO, 2002). A rapid development of 
natural products chemistry has resulted in a remarkable effect on the discoveries of 
bioactive components in natural sources. The present research work focuses on a 
plant named Garcinia hombroniana (from the Clusiaceae family). The bark of G. 
hombroniana was used in the extraction and isolation of some pure compounds. 
Characterization of their chemical structures was carried out using various 
spectroscopic techniques. These compounds were also assayed for their antioxidant, 
antibacterial, anticholinesterase and cytotoxic activities.  
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1.2 The Clusiaceae (Guttiferae) Family 
The Clusiaceae family in Peninsular Malaysia is composed of approximately 
37 genera and 1610 species. The plants are trees, shrubs or herbs which can grow 
from small to medium sized woody plants producing resinous white to yellow 
viscous exudates. Several plants of the Clusiaceae family produce important 
commercial products, edible fruits and more than 15% of oil from the seeds, and the 
timbers of many of its species are used for building houses and making furniture 
(Xiwen & Yan-hui, 1990). 
 
1.3 The Genus Garcinia 
Garcinia is the largest genus of the Clusiaceae family with about 450 species, 
indigenous to tropical Asia, tropical and southern Africa, Madagascar, North East 
Australia, West Polynesia and tropical America (Xiwen & Yan-hui 1990). It is a 
genus of small to medium sized trees which can be found from seashore to the 
lowland and up to the mountain forests. It is traditionally used in the treatment of 
abdominal pain, dysentery, diarrhea, infected wound, leucorrhoea, chronic ulcer and 
gonorrhea (Balemba et al., 2010; Braide, 1993; Moongkarndi et al., 2004a).  
 
1.4 Botanical Characterization of Garcinia  
Trees in this genus are either dioecious or polygamous. The flowers may be 
solitary, fascicled and umbelled or panicled, usually with four to five decussate or 
imbricate and free sepals, and four to five imbricate petals. The male flowers have 
two to four lobed free or joined stamens. Anthers are straight with a horse shoe 
shape. Female flowers have 2-12 celled ovaries.  The stigma is visible and sessile. 
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The berry is covered by tough peel and contains numerous large seeds suspended in a 
pulpy inner part (Xiwen & Yan-hui, 1990). 
 
1.5 Garcinia hombroniana Pierre 
 G. hombroniana is widely distributed and is native to Peninsular Malaysia 
where it can be found in the coastal regions, from the lowland forests near the sea to 
the lower mountain forests and the highlands, upper parts of Borneo, Cambodia, 
Thailand, Andaman, Nicobar Islands and Vietnam. The name Garcinia hombroniana 
was given by Pierre (1882-1885), after a French physician J. B. Hombron, who had 
collected this plant while travelling from Singapore to Malacca in the Peninsular 
Malaysia (Nazre, 2010). 
 
1.6 Botanical Characterization of G. hombroniana 
G. hombroniana, a seashore mangosteen (English) or manggis hutan (Malay) 
is an evergreen fast growing medium sized dioecious tree, reaching to a height of 
4.6-6.0 m and 1.8 m girth (Figure 1.1). It is the closest species to mangosteen (G. 
mangostana), and is thought to be one of its ancestors but interestingly the flowering 
time is much more different from that of mangosteen (Hammer, 2001). Due to the 
physical similarities of these two species, sometimes the nurseries mistakenly sell the 
seedlings as those of mangosteen.  G. hombroniana has straight stem with horizontal 
and opposite dense branches. Young twigs are smooth and green (Figure 1.2a) but 
the older bark is dark brown and rough with white latex (Figure 1.2b). Leaves are 
bright yellowish green which become glossy green on maturity (Figure 1.2c). 
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         Figure 1.1. Garcinia hombroniana Pierre 
  The fruit (Figure 1.2d) is smooth and spherical with a pinkish red peel.  The 
internal part is segmented, with yellowish pulp and has a good flavour. The flowers 
(Figure 1.2e) are whitish, with four sepals and petals, and 2.5 cm in diameter. The 
berry (Figure 1.2f) is ash-green in the beginning but turns crimson red on ripening. 
The pericarp (Figure 1.2d) is relatively thin. The seeds are about 6-8 in number and 
the ripened berry is full with soft, sour, juicy and pale creamish arillus of a peach 
flavour (John et al., 2008).  
 
1.7 Uses of G. hombroniana 
The fruit of G. hombroniana is aromatic with thin and sour flesh.  It is used in 
making juices and jellies. The timber is used to make houses and oars. The roots and 
leaves are used medicinally to relieve itching and as a protective medicine after 
childbirth (Pierre, 1882-1885). 
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(a) Young twig (b) Bark 
                            
(c) Leaves (d) Fruit and pericarp 
 
  
(e) Flower (f) Unripened berry 
 
Figure 1.2. Parts of G. hombroniana 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Phytochemical Studies of Garcinia 
Garcinia is a rich source of bioactive secondary metabolites including 
oxygenated prenylated xanthones (Peres et al., 2000), benzophenones (Magadulla et 
al., 2008), flavonoids and biflavonoids (Harati et al., 2007), and triterpenes 
(Rukachaisirikul et al., 2005a). These phenolic compounds possess various 
pharmacological properties such as antioxidative, anti-inflammatory, antiallergic, 
antimicrobial, antimalarial, antihepatotoxic and HIV inhibitory activities (Gustafson 
et al., 1992; Hay et al., 2004). 
  
2.2 Phytochemical Investigation of G. hombroniana 
Previous phytochemical investigation of the different parts of G. 
hombroniana such as stem wood, pericarp, leaves and twigs had resulted in the 
isolation of different classes of compounds including xanthones, flavonoids, 
biflavonoids and triterpenes. The chemical constituents isolated from G. 
hombroniana up to the year 2013 are reported in this thesis using Scifinder database. 
 
2.2.1 Chemical Constituents Isolated from the Stem Wood of G. hombroniana 
Bronianone (1) is the only compound isolated by Ollis et al. (1969) from the 
stem wood of G. hombroniana. 
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2.2.2 Chemical Constituents Isolated from the Pericarp of G. hombroniana 
Rukachaisirikul et al. (2000) reported the isolation of triterpenes as the major 
compounds from dichloromethane extract of the pericarp of G. hombroniana.  The 
compounds include (24E)-3α-hydroxy-17,14-friedolanostan-8,14,24-dien-26-oic acid
 (2), garcihombronane B (3), garcihombronane C (4), garcihombronane D (5) and 
garcihombronane E (6).  
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2.2.3 Chemical Constituents Isolated from the Leaves of G. hombroniana 
Rukachaisirikul et al. (2005a) further reported the isolation of triterpenoids 
along with some other classes of compounds from the leaves of G. hombroniana. 
The compounds include garcihombronane F (7), garcihombronane G (8), 
garcihombronane H (9), monoacetate of garcihombronane H (10), garcihombronane I 
(11), monoacetate of garcihombronane I (12), garcihombronane J (13), methyl (25R)-
3β-hydroxy-23-ox-9,15-lanostadien-26-oate (14), vitexin (15), isovitexin (16), blum-
inol-C-9-O-β-D-apiofuranosyl-(1→6)-β-D-glucopyranoside (17), vomifoliol-9-O-β-D
-apiofuranosyl (1→6)-β-D-glucopyranoside (18) and garcihombronanes B-E. 
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2.2.4 Chemical Constituents Isolated from the Twigs of G. hombroniana 
Klaiklay et al. (2013) reported triterpenes and other compounds from the 
twigs of G. hombroniana. The compounds include (22Z, 24E)-3β,9α-dihydroxy-
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17,14-friedolanostan-14,22,24-trien-26-oic acid (19), garcihombronane K (20), 
Monoacetate of garcihombronane K (21)  garcihombronane L (22), garcihombronone 
A (23), garcihombronone B (24),  garcihombronone C (25), garcihombronone D 
(26), norathyriol (27), gentisein (28), 1,3,6,7-tetrahydroxy-8-prenylxanthone (29), 
cheffouxanthone (30), bangangxanthone A (31), toxyloxanthone B (32), 1,3,5,7-
tetrahydroxy-2-(3,7-dimethyl-6-hydroxyocta-2-7-dien)xanthone (33)*, volkensiflav-
one (34), naringenin 7-O-β-D-glucuronide (35)*,  eriodictyol 7-O-β-D-glucuronide 
(36)*, 4-hydroxybenzoic acid (37) and protocatechuic methyl ester (38). 
Saputri and Jantan (2012) also reported 3,5,3',5'-tetrahydroxy-4-methoxybenzophen-
one (39) and 1,7-dihydroxyxanthone (40) from the methanol extract of the twigs of 
G. hombroniana.      
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*Klaiklay PhD Thesis, 2009 
 
2.3 Pharmacological Investigation of G. hombroniana 
The Garcinia species are well known tropical trees used in the folk medicine 
for the treatment of various diseases and have been reported for their significant 
pharmacological properties. G. hombroniana is reported to have antiplatelet 
aggregation activities.  Saputri and Jantan (2012) reported that the crude methanol 
extract of the twigs of G. hombroniana and the two compounds: (39) and (40) 
isolated from it exhibited strong copper mediated LDL antioxidation with IC50 of 6.6 
and 1.7 μM, respectively.  It was further reported that compound (39) showed 
archidonic acid (AA, IC50 = 53.6 μM), adenosine diphosphate (ADP, IC50 = 125.7 
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μM) and collagen-induced (IC50 = 178.6 μM) antiplatelet aggregation activities while 
compound (40) displayed a selective inhibition against ADP induced aggregation 
with IC50 of 5.7 μM. The crude methanol extract of the twigs of G. hombroniana 
showed antibacterial activities against S. aureus and MRSA with the MIC values of 
128 and 200 μg/mL, respectively. Compounds (30) and (31) displayed moderate 
activities against MRSA with MIC values of 64.0 and 32.0 μg/mL, respectively. In 
addition, Klaiklay et al. (2013) also reported that compound (30) has a good activity 
against S. aureus with a MIC value of 16.0 μg/mL.   
 
2.4 Problem Statement 
The biodiversity source in Malaysia is one of the biggest in the world but its 
potential uses need to be identified and exploited. During the compilation of the 
economic products of the Malay Peninsula, Burkill (1966) has reported that 1,300 
plants were used as folk medicine. The rich biodiversity of Malaysia, the public 
interest in herbal medicine and the contribution of industries and multinationals in 
herbal medicine have led to new emphasis of the medicinal plant research.  Extensive 
work on the isolation and identification of chemical compounds from the Garcinia 
species, as well as their biological activities have been reported as many species from 
this genus are easily available and are known for their medicinal values. Previously 
the stem wood, twigs, pericarp and leaves of G. hombroniana have been investigated 
for their chemical constituents and biological activities (Klaiklay et al., 2013; 
Rukachaisirikul et al., 2005a; Saputri & Jantan, 2012). However, to the best of our 
knowledge, there is no authentic previous study on the bark of G. hombroniana 
either in terms of phytochemical investigation or bioactivities. Taking this into 
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account, this research work was aimed to isolate, purify and identify biologically 
active compounds from the bark of G. hombroniana. 
 
2.5 Objectives of the Research 
      The objectives of this research are: 
1. To isolate the chemical constituents from dichloromethane and ethyl acetate 
extracts of the bark of G. hombroniana. 
2. To characterize and identify the isolated chemical constituents using different 
spectroscopic techniques such as UV, IR, NMR (1D and 2D) and mass 
spectrometry (EI-MS and HR/LR-ESI-MS). 
3. To evaluate the phenolic and flavonoid contents and to correlate these 
contents to the antioxidant activities of extracts. 
4. To evaluate the antibacterial, anticholinesterase and anticancer activities of 
the extracts and some selected pure compounds. 
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CHAPTER 3 
MATERIALS AND METHODS 
 
3.1 Plant Material 
The plant (G. hombroniana) was collected in April 2010 from Penang 
Botanic Garden, Malaysia. A voucher specimen (PBGK12) has been deposited at the 
herbarium of this garden. 
 
3.2 Chemicals  
All the chemicals and solvents used for extraction, isolation and biological 
activities were either of analytical or HPLC grade. 
 
3.2.1 Chemicals for Extraction and Isolation  
Acetone, AR grade (QRёC, Malaysia); acetone-d6 for NMR 99.5 atom% D 
Nitrogen flushed (Merck, Germany); aluminium chloride AlCl3.6H2O (Merck, 
Germany); chloroform CHCl3, AR grade (QRёC, Malaysia); chloroform-d1, with 
0.03% TMS (v/v), 99.8 atom% D, stabilized with silver foil (Merck, Germany); 
DMSO-d6  99.8 atom% D (Merck, Germany); ethyl acetate EtOAc, AR grade, 
(QRёC, Malaysia); ethanol 95% and 99% (QRёC, Malaysia); methanol MeOH, AR 
grade (QRёC, Malaysia); MeOD-d4 99.8 atom% D, (ACROS, USA); pyridine 
C5D5N (Merck, Germany); sephadex LH-20 (Sigma-Aldrich, USA); silica gel 60 for 
column chromatography (0.040-0.063 mm; 230-400 mesh, Merck, Germany); 
sodium carbonate Na2CO3, (Systerm, Malaysia); sodium hydroxide NaOH, 
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(Systerm, Malaysia); sulfuric acid H2SO4, (R & M Chemicals Essex, U.K); TLC 
aluminium sheets, pre-coated silica gel 60 F254, 20 cm x 20 cm (Merck, Germany). 
 
3.2.2 Chemicals for Biological Activities Evaluation 
Acetylthiocholine iodide (ATCI), (Sigma-Aldrich, USA); 2,2'-azino-bis-3-
ethyl benzthiazoline-6-sulphonic acid (ABTS), (Sigma Aldrich, Germany); buffer pH 
3.6 (Sigma-Aldrich, USA); S-butyrylthiocholine chloride (BTCCl) (Sigma-Aldrich, 
USA); cytotoxicity detection kit (Roche Diagnostics, Germany); deionized water; 
dimethyl sulfoxide DMSO, (Sigma-Aldrich, USA); 5,5-dinitrobenzoic acid (DTNB), 
(Sigma- Aldrich, USA); 2,2-diphenyl-1-picrylhydrazyl (DPPH), (Sigma Aldrich, 
Germany); ferric chloride (FeCl3.6H2O), (Bendosen Laboratory Chemicals); 10% 
fetal bovine serum (Gibco, USA); Folin-Ciocalteu Reagent (Sigma Aldrich, 
Germany); gallic acid (Sigma Aldrich, Germany); glioma DBTRG cell lines 
[American Type Culture Collection  (ATCC) Rockville, USA]; human breast cancer 
MCF-7 cell lines [American Type Culture Collection (ATCC), Rockville, USA]; 
hydrochloric acid HCl, (R & M Chemicals Essex, U.K); 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox), (Sigma Aldrich, Germany); Muller-
Hinton agar and broth MHA and MHB, (Oxoid, England), p-nitrotetrazolium violet 
(INT), (Sigma-Aldrich, USA); osteosarcoma U2OS cell lines, [American Type 
Culture Collection (ATCC), Rockville, USA];  potassium persulfate (K2S2O8), 
(Merck, Germany); prostate PC3 cell lines, [American Type Culture Collection 
(ATCC), Rockville, USA]; physostigmine (Sigma-Aldrich, USA); quercetin (Aldrich 
Milwukee, WI); rutin (Aldrich Milwukee, WI); 2,4,6-tripyridyl-s-triazine TPTZ, 
(Merck, Germany). 
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3.3 Instruments Used for Structures Elucidation and Biological Activities 
3.3.1 Melting Point 
Melting points of the isolated pure compounds were determined by a Stuart 
Scientific SMP-1 (UK) melting point apparatus. 
 
3.3.2 Infrared (IR) Spectroscopy 
IR spectra of the isolated compounds were recorded on a Perkin-Elmer 
System 2000 FT-IR spectrometer (England, UK). The samples were prepared as 
potassium bromide (KBr) discs and scanned in a measurement range of 400-4000 
cm-1. 
 
3.3.3 Nuclear Magnetic Resonance (NMR) Spectroscopy 
NMR spectra of the isolated pure compounds were recorded on a Bruker 
Avance 500 spectrometer operated at 500 MHz for 1H-NMR, and 125 MHz for 13C-
NMR, respectively. The measurements of the samples were performed in deuterated 
solvents (chloroform-d1, dimethyl sulfoxide-d6, methanol-d4, acetone-d6 and 
pyridine-d5). The coupling constants (J) were reported in Hertz (Hz). 
 
3.3.4 Direct Probe Mass Spectrometry 
Direct probe mass spectrometry through EI-MS and LR/HR-ESI-MS spectra 
were respectively recorded on an Agilent 5975C MSD and ThermoFinnigan 
MAT95XL mass spectrometers at the National University of Singapore (NUS), 
Singapore.  
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3.3.5 Ultraviolet (UV) Spectroscopy 
UV spectra were recorded using a Perkin Elmer, Lambda 25 UV/Vis 
spectrometer in the region of 200-500 nm. The UV spectra for biflavonoids were 
measured using different shift reagents according to the method described by Bloor 
(2001). Stock solutions of the biflavonoids (EN3-EN5) were prepared by dissolving 
about 0.1 mg of compounds in 10 mL of methanol and divided each into three parts. 
The UV spectra were then measured using the following procedure.  
i. The UV spectra of the samples prepared in methanol were measured. 
ii. The spectra were recorded immediately after the addition of few drops of 
NaOMe (2.5 g metallic Na/100 mL MeOH) to first part of the stock 
solutions. 
iii. After 5 minutes the NaOMe spectra were recorded again. 
iv. The spectra were recorded immediately after the addition of 3 drops of 
5% AlCl3 reagent to second part of the stock solutions. 
v. The spectra were recorded immediately after the addition of 6 drops of 
50% HCl reagent to the solutions of step (iv). 
vi. The spectra were measured after the addition and mixing of anhydrous 
sodium acetate (NaOAc) powder to third part of the stock solutions. The 
quantity of NaOAc added was such that about 2 mm layer settled to the 
bottom of the cuvette. 
vii. The spectra were recorded immediately after the addition of anhydrous 
boric acid powder to the solutions used in step (vi). 
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3.3.6 Circular Dichroism (CD) Spectroscopy 
The absolute stereochemistry of EN5 was determined using Jasco-815 
spectrometer at 25 ᵒC (Scan range λ = 200-350 nm, cell length = 10 mm). 
 
3.3.7 X-Ray Crystallography Analysis 
Single crystal X-Ray structure analysis of compound EN2 was performed on 
a Bruker SMART APEXII CCD area detector diffractometer at the School of 
Physics, USM. The X-Ray crystallographic structure was solved and refined using 
SHELXTL software. 
 
3.3.8 Microplate Reader 
A Tecan Infinite 200 Pro Microplate spectrometer was used for the evaluation 
of the biological assays. Absorbance at different concentrations was measured with 
the microplate reader. 
 
3.4 Extraction Procedure 
The air dried ground bark (5.2 kg) of G. hombroniana was sequentially 
extracted using Soxhlet extractor with n-hexane, dichloromethane, chloroform, ethyl 
acetate and methanol at 40 ᵒPC. The filtered extracts were evaporated to dryness using 
a rotary evaporator at 40 ᵒPC to give a 30.1 g of n-hexane extract, 50.0 g 
dichloromethane extract, 5.0 g of a chloroform extract, 18.2 g of ethyl acetate extract 
and 30.1 g of a methanol extract. Another 100 g was extracted by the direct 
maceration into distilled hot water for 24 h to give aqueous-di extract (Figure 3.1).  
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Figure 3.1. Extraction procedure of G. hombroniana bark 
 
Air dried ground bark 
(5.3 kg) 
Soxhlet extraction 
5.2 kg 100 g 
Maceration 
     Direct maceration in  
     dist. H2O for 24 hours 
       n-hexane extract 
(30.1 g) 
 Dichloromethane extract 
(50.0 g) 
 Chloroform extract 
(5.0 g) 
    Ethyl acetate extract 
(18.2 g) 
 Methanol extract 
(30.1 g) 
Aqueous extract (aqueous-di) 
(7.0 g) 
Aqueous extract 
Partition in separatory funnel with dist. H2O 
Organic solvents were removed 
under reduced pressure at 40 °C 
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3.5 Phytochemical Screening 
The crude n-hexane, dichloromethane, chloroform, ethyl acetate, methanol 
and aqueous extracts, and the extract (aqueous-di) were screened for the detection of 
some secondary metabolites such as terpenoids, phytosterols, phenolics, flavonoids, 
carbohydrates, reducing sugars, alkaloids, phlobatannins and tannins, following the 
procedures of Indian Pharmacopoeia (1985). 
 
3.5.1 Detection of Carbohydrates and Glycosides 
Molish’s Test: Few drops of α-naphthol were added to 2 mL filtrate of the 
crude extracts. After mixing and shaking, 1 mL of sulfuric acid was gradually added 
along the sides of the test tube and allowed to stand. A violet ring indicated the 
presence of carbohydrates. 
Fehling Solution’s Test: 1 mL of Fehling’s solution was added to 2 mL 
filtrate of crude extracts and boiled at 100 ᵒC. The formation of red precipitate 
indicated the presence of reducing sugars. 
 
3.5.2 Detection of Proteins and Amino Acids 
Biuret Test: A Few drops of 2% CuSO4 solution were added to 5 mL filtrate 
of the crude extracts. Then 2 mL of 95% ethanol and excess of potassium hydroxide 
pallets were added. An absence of pink colour indicated an absence of proteins. 
Ninhydrin Test: Few drops of ninhydrin solution (5% w/v in acetone) were 
added to 2 mL filtrate of the crude extracts. Appearance of no purple colour revealed 
the absence of amino acids. 
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3.5.3 Detection of Terpenoids (Salkowski’s Test) 
  2 mL chloroform was added to 5 mL filtrate of the crude extracts, and then 3 
mL of conc. H2SO4 was added slowly along the sides of the test tube. A reddish 
interface showed the presence of terpenoids. 
 
3.5.4 Detection of Phytosterols (Liebermann-Burchard’s Test) 
2 mL of acetic anhydride was added to 5 mL filtrate of the crude extracts. 
Afterwards, 1-3 drops of conc. H2SO4 were added by the sides of the test tube. Array 
of the colour change showed the presence of phytosterols. 
 
3.5.5 Detection of Phenolic Compounds 
Ferric Chloride Test: A few drops of 5% ferric chloride solution were added 
to 2 mL filtrate of the crude extracts. Formation of dark green colour indicated the 
presence of phenolic compounds. 
Lead Acetate Test: 3 mL of 10% lead acetate solution was added to 5 mL 
filtrate of the crude extracts. A white precipitate indicated the presence of phenolic 
compounds.  
 
3.5.6 Detection of Flavonoids  
NH4OH Solution Test: 1 mL of 10% NH4OH solution was added to 5 mL 
filtrate of the crude extracts. A formation of yellow florescent colour indicated the 
presence of flavonoids. Furthermore, 5 mL of DMSO was added to it, heated it, and 
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magnesium chloride and 1 mL of conc. HCl was added. Appearance of red colour 
showed the presence of flavonoids. 
NaOH Solution Test: 4 mL of dil. NaOH solution was added to 2 mL filtrate 
of the crude extracts. The formation of golden yellow colour revealed the presence of 
flavonoids. 
 
3.5.7 Detection of Tannins 
A few drops of 5% ferric chloride were added to 5 mL filtrate of the crude 
extracts. A brown colour indicated the presence of tannins. 
 
3.5.8 Detection of Phlobatannins 
5 mL of deionized water was added to 5 mL filtrate of the crude extracts. 
Then a few drops of 1% HCl were added and boiled it at 100 ᵒC for 10 min. The 
absence of formation of red precipitate indicated the absence of phlobatannins. 
 
3.5.9 Detection of Alkaloids 
A few drops of Wagner’s reagent were added to 5 mL filtrate of the crude 
extracts. Orange precipitate showed the presence of alkaloids. 
 
3.6 Separation Techniques 
3.6.1 Thin Layer Chromatography (TLC) 
The crude extracts were preliminary examined by thin layer chromatography, 
followed by the determination of the appropriate solvent systems. The selected 
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solvent systems were used for the column chromatographic separation of compounds 
in the crude extracts. The purity of the isolated compounds was also checked with 
TLC. In this phytochemical investigation, pre-coated TLC plates of silica gel 60 F254 
(20 x 20) on aluminium sheets were used. The developed plates were visualized with 
a UV light (Vilber Lournet, multiband UV-254/365 nm) and/or by spraying them 
with 95% methanolic H2SO4 or the Libermann-Burchard’s reagent (Horborne, 1998) 
followed by heating with a heat gun at 100-105 ᵒC. 
 
3.6.2 Column Chromatography (CC) 
Column chromatography was carried out using silica gel (230-240 mesh, 
0.040-0.060 mm) and Sephadex LH-20 (bead size 25-100 μ). Elution was carried out 
with a gradient solvent system of increasing polarity (n-hexane, chloroform, ethyl 
acetate, acetone and methanol) when silica gel was used as an absorbent. However, 
100% methanol was used as an eluting solvent with Sephadex LH-20.  
 
3.7 Isolation and Purification 
3.7.1    Dichloromethane (DCM) Extract 
The DCM extract (20.0 g) was subjected to silica gel CC. Elution was carried 
out using n-hexane, n-hexane-ethyl acetate, ethyl acetate-methanol in a polarity 
gradient of 10:0, 9:1, 8:2, 7:3, 6:4, 1:1, 4:6, 3:7, 2:8 and 0:10. Eluents were collected 
in 42 fractions DFA1 to DFA42. Fractions having similar TLC profiles were 
combined to give nine fractions (DFB1 to DFB9).  
Fraction DFB1 (3.8 g) with a greenish white crystalline solid was 
rechromatographed on silica gel CC, eluted with n-hexane and ethyl acetate. Sub-
